Lavipharm Sa Stock Five Year Return
| LAVI Stock | EUR 0.85 0.00 0.00% |
Lavipharm SA fundamentals help investors to digest information that contributes to Lavipharm's financial success or failures. It also enables traders to predict the movement of Lavipharm Stock. The fundamental analysis module provides a way to measure Lavipharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lavipharm stock.
Lavipharm |
Lavipharm SA Company Five Year Return Analysis
Lavipharm's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Lavipharm Five Year Return | 4.13 % |
Most of Lavipharm's fundamental indicators, such as Five Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lavipharm SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Lavipharm SA has a Five Year Return of 4.13%. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers - Major industry. The five year return for all Greece stocks is notably lower than that of the firm.
Lavipharm Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lavipharm's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lavipharm could also be used in its relative valuation, which is a method of valuing Lavipharm by comparing valuation metrics of similar companies.Lavipharm is currently under evaluation in five year return category among related companies.
Lavipharm Fundamentals
| Return On Asset | 0.0403 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 59.98 M | |||
| Shares Outstanding | 18.29 M | |||
| Shares Owned By Insiders | 67.47 % | |||
| Price To Earning | 12.42 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 41.37 M | |||
| Gross Profit | 15.89 M | |||
| EBITDA | 4.72 M | |||
| Net Income | 1.72 M | |||
| Cash And Equivalents | 1.85 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 40.54 M | |||
| Current Ratio | 1.29 X | |||
| Book Value Per Share | (0.47) X | |||
| Cash Flow From Operations | 3.82 M | |||
| Earnings Per Share | 0.04 X | |||
| Beta | 0.66 | |||
| Market Capitalization | 8.56 M | |||
| Total Asset | 82 M | |||
| Retained Earnings | (181 M) | |||
| Working Capital | (66 M) | |||
| Current Asset | 21 M | |||
| Current Liabilities | 87 M | |||
| Z Score | -2.8 | |||
| Five Year Return | 4.13 % |
About Lavipharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lavipharm SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lavipharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lavipharm SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lavipharm in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lavipharm's short interest history, or implied volatility extrapolated from Lavipharm options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lavipharm SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Lavipharm Stock analysis
When running Lavipharm's price analysis, check to measure Lavipharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lavipharm is operating at the current time. Most of Lavipharm's value examination focuses on studying past and present price action to predict the probability of Lavipharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lavipharm's price. Additionally, you may evaluate how the addition of Lavipharm to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stocks Directory Find actively traded stocks across global markets |